Cypress Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,325
Closed -$252K 177
2018
Q3
$252K Sell
1,325
-226
-15% -$41.5K 0.07% 161
2018
Q2
$259K Buy
+1,551
New +$249K 0.08% 159
2017
Q4
Sell
-1,286
Closed -$264K 192
2017
Q3
$264K Hold
1,286
0.06% 166
2017
Q2
$313K Buy
1,286
+25
+2% +$5.88K 0.06% 158
2017
Q1
$301K Sell
1,261
-100
-7% -$23.3K 0.06% 177
2016
Q4
$286K Hold
1,361
0.05% 182
2016
Q3
$313K Buy
1,361
+60
+5% +$14.7K 0.06% 167
2016
Q2
$301K Sell
1,301
-65
-5% -$15K 0.06% 167
2016
Q1
$366K Buy
1,366
+100
+8% +$28.6K 0.07% 155
2015
Q4
$396K Buy
1,266
+50
+4% +$14.9K 0.08% 146
2015
Q3
$331K Hold
1,216
0.07% 151
2015
Q2
$369K Buy
+1,216
New +$363K 0.07% 158

Other funds holding AGN

Cypress Asset Management's AGN Position: Q4 2018 in Review

Cypress Asset Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,325 shares — an estimated $252K sold.

Cypress Asset Management first reported a position in AGN in Q2 2015 and held it in 12 quarters. The position peaked at $396K in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Cypress Asset Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Cypress Asset Management sold 1,325 Allergan plc shares in Q4 2018, an estimated $252K.
  • Cypress Asset Management first reported a position in Allergan plc in Q2 2015 and held it in 12 quarters.
  • Cypress Asset Management's Allergan plc position peaked at $396K in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Cypress Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.